In PCCs/PGLs, the increased stabilization of the HIF2α isoform, encoded by the endothelial PAS domain-containing protein 1 (EPAS1) gene, has been reported to be associated with rapid tumor progression and worse prognosis [25,26], thus presenting itself as a promising target for future treatment approaches. The gene discussed is EPAS1; the disease is neoplasm.